Home / Blog

Zscaler Inc (ZS) Q4 Earnings Preview: What to Watch

Zscaler reports Q4 2026 earnings on September 3. We analyze the sales leadership transition, fiscal 2027 guidance, and key growth metrics for the cybersecurity firm.

Stock AnalysisFintwit Team·Sep 1, 2026·3 min read
Zscaler Inc (ZS) Q4 Earnings Preview: What to Watch
Zscaler (ZS) enters its Q4 2026 earnings report with a 65% probability of beating estimates, according to historical data. The company faces significant pressure to stabilize growth expectations following a May 2026 sell-off triggered by conservative fiscal 2027 guidance.

The setup

Zscaler is navigating a complex transition period characterized by sales leadership turnover and a shift in long-term growth expectations. Investors are looking for evidence that the company can maintain its competitive edge in the Zero Trust Exchange market despite macroeconomic headwinds.

The market remains divided on the stock's trajectory. While some analysts maintain bullish stances citing strong underlying demand, others have adopted a cautious outlook due to field checks and decelerating top-line growth.

  • Robert Baird analyst Shrenik Kothari maintains a Buy rating with a $220 price target.
  • Evercore ISI recently placed Zscaler on its Tactical Underperform list.
  • JPMorgan maintains an Overweight rating with a $215 price target.
  • Rising global bond yields continue to pressure valuation multiples for high-growth SaaS companies.

Consensus numbers

Wall Street expects Zscaler to report non-GAAP EPS of $1.09 for the fourth quarter. Revenue is projected to reach $876.96 million.

The company has a consistent history of exceeding quarterly expectations, though the magnitude of these beats is under scrutiny as growth rates normalize.

  • Q4 2026 EPS Estimate: $1.09.
  • Q4 2026 Revenue Estimate: $876.96 million.
  • Historical Q3 2026 performance: $1.08 EPS on $850.48 million revenue.
  • Historical Q2 2026 performance: $1.01 EPS on $815.75 million revenue.
  • Historical Q1 2026 performance: $0.96 EPS on $788.11 million revenue.
Consensus numbers

What we'll watch on the call

The primary focus for investors will be the updated fiscal 2027 outlook. Management previously signaled a growth range of 16-17%, and any deviation from this baseline will likely dictate the immediate share price reaction.

Operational execution remains a key theme. The market needs clarity on how recent sales leadership changes have impacted pipeline conversion and deal velocity.

  • ARR growth: Is the organic growth rate stabilizing or continuing to decelerate from the 25% level?
  • Sales organization: Are there signs of disruption in deal execution following Q3 leadership departures?
  • Data security: Can the segment growing north of 30% provide a meaningful offset to core platform deceleration?
  • Operating margins: Can the company maintain record non-GAAP margins while funding R&D and infrastructure?
  • AI-security features: What is the current contribution to new customer acquisitions and upsell activity?

Fintwit's AI verdict

The sentiment surrounding Zscaler remains cautious as the company balances its long-term potential in AI-driven security against immediate execution risks. Investors are waiting for management to prove that the recent growth deceleration is a temporary hurdle rather than a structural shift in the business model.

Fintwit AI verdict
ZS
HOLD
AI investment score•• / 100
Price target$•••
Risk rating•••••
Time horizon•• months
Sentiment breakdown•••
Unlock the full ZS breakdown
Free Fintwit account

The upcoming earnings call will serve as a litmus test for whether the current valuation reflects a bottom or if further consolidation is required. Market participants are closely monitoring the commentary for signs of stability in the go-to-market organization.

What to watch: Zscaler will report its Q4 2026 financial results after the market close on September 3, 2026.
Want this analysis on every stock you own?
Fintwit gives you AI stock analysis, real-time signals from X, and curated picks — built on the same data this post is grounded in.
Start Free Trial
Free to start. Premium just $9/mo — half the price of other research tools.